NIH-funded research R01 grant

Developing advanced techniques to analyze RNA modifications

Official title: Development of Next-Generation Mass Spectrometry-based de novo RNA Sequencing for all Modifications

Funded at State University of New York at Albany · NIH-11012884 · Data updated 2026-11-12

This study is working on a new way to analyze RNA, which could help us better understand how changes in RNA are linked to diseases like breast cancer, type-2 diabetes, and obesity, ultimately benefiting patients by providing more insights into their conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University of New York at Albany
NIH-funded
Lab location1 site (Albany, United States)
Project startMarch 1, 2023
Project endFebruary 28, 2027
Funding year2025
Award (this year)$660,378
NIH project number5R01HG012853-04
Project IDNIH-11012884 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by diseases such as breast cancer, type-2 diabetes, or obesity.

Less likely to help

Patients with conditions unrelated to RNA modifications may not receive any benefit from this research.

What this research studies

This research focuses on creating a new mass spectrometry method to accurately sequence RNA and identify all its modifications. By addressing the limitations of current technologies, this project aims to provide a comprehensive understanding of RNA sequences, which is crucial for understanding various diseases. Patients may benefit from insights gained about RNA modifications related to conditions like breast cancer, type-2 diabetes, and obesity. The approach involves advanced analytical techniques to ensure that all modifications are detected and characterized.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools and treatments for diseases linked to RNA modifications.

How similar studies have gone: While mass spectrometry has been used in related fields, this specific approach to RNA modifications is novel and has not been extensively tested.

Where this research is happening

  • State University of New York at Albany
    Albany, United States
    Active

Researchers

  • Principal investigator: Zhang, Shenglong — State University of New York at Albany
  • Study coordinator: Zhang, Shenglong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.